Decreased Expression of Sprouty2 in Schizophrenia and Bipolar Disorder
Author Information
Author(s): Pillai Anilkumar
Primary Institution: Medical College of Georgia, Veterans Affairs Medical Center
Hypothesis
The study investigates whether Sprouty2 is abnormally expressed in schizophrenia and is associated with changes in BDNF mRNA.
Conclusion
The study found decreased expression of Sprouty2 associated with changes in BDNF, suggesting these decreases may be secondary to treatment rather than significant in the disease process.
Supporting Evidence
- Sprouty2 and BDNF gene expression were significantly decreased in both schizophrenia and bipolar disorder.
- A significant correlation between Sprouty2 and BDNF expression was found in all groups.
- Long-term treatment with antipsychotic drugs showed differential effects on Sprouty2 and BDNF levels in rats.
Takeaway
The study shows that people with schizophrenia and bipolar disorder have lower levels of a protein called Sprouty2, which is linked to another protein called BDNF that helps brain cells grow.
Methodology
Gene expression of Sprouty2 and BDNF was analyzed using quantitative real-time PCR in dorsolateral prefrontal cortex samples from individuals with schizophrenia, bipolar disorder, and normal controls.
Potential Biases
Potential bias due to the retrospective nature of postmortem studies and the influence of antipsychotic medications on gene expression.
Limitations
The study's findings may be influenced by confounding variables such as age, duration of illness, and medication history.
Participant Demographics
The study included 35 individuals with schizophrenia, 31 with bipolar disorder, and 34 psychiatrically normal controls.
Statistical Information
P-Value
p=0.0098 for schizophrenia, p=0.003 for bipolar disorder
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website